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Abdominal pain is one of the most common presenting complaints to the emergency department. 
Mesenteric venous thrombosis represents an important cause to consider in patients with acute 
abdominal pain. The diagnosis is often delayed, and cases traditionally have been identified either 
at laparotomy or at autopsy. In this case, we describe a 21-year-old female with acute onset of 
right lower quadrant pain attributable to a hyperhomocysteinemia related non-occlusive superior 
mesenteric vein thrombosis. This case highlights how the use of computed tomography in select 
cases can lead to earlier recognition of this condition and increasingly allow for non-surgical 
treatment. [West J Emerg Med 2011;12(2):262-265.]
INTRODUCTION
Abdominal pain represents one of the most common 
presenting complaints to United States emergency 
departments (ED). In 2006 alone, 10% of the 119.2 million 
visits listed nausea, vomiting and abdominal pain as the chief 
complaints.1 Only a very small percentage of ED patients with 
abdominal pain will have appendicitis, and 25% or more of 
persons presenting with abdominal pain will receive the 
diagnosis of undifferentiated abdominal pain.1 One of the 
important causes to consider in the differential of the ED 
patient with acute or subacute abdominal pain is mesenteric 
ischemia. 
Mesenteric venous thrombosis (MVT) is well established 
as a cause of intestinal ischemia that is distinct from 
mesenteric arterial occlusion and accounts for approximately 
15% of all mesenteric ischemia cases.2,3 Unfortunately, the 
symptoms of MVT are subtle and not generally associated 
with characteristic laboratory abnormalities or distinct 
physical exam findings. This traditionally led to a delay 
in diagnosis of this condition until ischemia developed, at 
which point MVT was most often identified at laparotomy 
or on autopsy.4,5 The presentation of non-occlusive thrombus 
can evolve over days to weeks and is often characterized by 
vague, nonspecific symptoms with delay in diagnosis due to 
the slow progression of symptoms.6,7 Early identification of 
the condition allows for conservative treatment with anti-
coagulation and improved outcomes.8 This case highlights 
how the use of contrast enhanced computed tomography (CT) 
in the ED when indicated based on history, physical exam and 
laboratory findings can lead to earlier diagnosis of MVT.
CASE REPORT
A 21-year-old female presented to the ED with two days 
of acute, sharp, right lower quadrant pain (RLQ). Her pain had 
started as periumbilical pain, which migrated to the RLQ. She 
endorsed one week of nausea and vomiting without anorexia 
and did not relate pain to meals. She denied any traumatic 
events. Her past medical history was significant for a gonadal 
vein thrombosis after the birth of her first child and chronic 
pelvic pain for the previous seven months. One week prior to 
her ED presentation, she had completed a six-month course of 
warfarin for the gonadal vein thrombosis. At the time of 
presentation, she was on no medications and had no known 
drug allergies. There was no family history of bleeding or 
clotting disorders. Her physical exam was significant for RLQ 
abdominal tenderness without guarding, rigidity or peritoneal 
signs. 
The patient underwent a workup for abdominal pain in the 
ED consisting of a complete blood count, chemistry panel, 
urinalysis, liver function tests and lipase, as well as a contrast 
CT scan of her abdomen and pelvis to evaluate for 
appendicitis. Basic laboratory values were normal. CT showed Volume XII, no. 2  :  May 2011    263  Western Journal of Emergency Medicine
a partially occluding thrombus in the superior mesenteric vein 
(SMV). Her presentation was consistent with intermittent 
ischemia in a watershed distribution of the cecum, appendix 
and terminal ileum. The patient was anticoagulated with 
weight-based enoxaparin and referred to hematology. A 
detailed outpatient workup revealed elevated serum 
homocysteine levels, but was negative for other causes of 
coagulopathy. She has been subsequently treated with vitamin 
B12, folate and warfarin. 
A follow-up CT at one month showed full resolution of 
the SMV thrombosis, and at six months she had no residual 
RLQ pain (Figure 1).
DISCUSSION
Various studies show the diagnosis of MVT is associated 
with mortality rates of approximately 20-38%. Those same 
studies cite early diagnosis, before the development of 
intestinal ischemia, and early use of anticoagulation as 
associated with decreased mortality.3,5,7,8 Improvements in 
imaging modalities and increased awareness of this condition 
have led to increasing opportunities for non-operative 
management.8,9 CT is generally the imaging modality of 
choice due to its high sensitivity (90-100%), wide availability 
and relatively low cost. Magnetic resonance imaging (MRI) 
also has been used to identify the condition and has shown a 
similarly high sensitivity. Ultrasound with Doppler analysis of 
flow in the mesenteric and portal venous systems has also 
been used with success; however, ultrasound reports a lower 
sensitivity (73-80%) and can be technically difficult to 
perform and interpret.8 No characteristic laboratory 
abnormalities are associated with MVT. Observations from a 
small group of Swedish patients suggest leukocytosis as the 
most common laboratory abnormality. They also suggest that 
a normal D-dimer can be used as an exclusion test for this 
diagnosis, although no reports exist on the reliability of this 
test for excluding MVT.7
Poor prognostic indicators for MVT include an acute 
presentation, defined as less than three days of symptoms at 
presentation, and the presence of bowel ischemia. In general, 
the diagnosis is characterized by a prodromal period of days to 
weeks of abdominal pain that is usually out of proportion to 
physical findings.2,5,9 A study out of Pakistan described 20 
cases of MVT and found the most common clinical findings 
included abdominal pain, abdominal tenderness and absent 
bowel sounds. Patients were typically older, with the highest 
proportion of patients presenting between ages 70-79 years.7 A 
recent meta-analysis found that in contrast to the general 
presentation of MVT, patients with hyperhomocysteinemia 
were slightly younger. The mean age of patients in this study 
was 57 years old.10 
Mesenteric vein thrombosis is categorized as primary if 
no cause is identified or secondary if a hypercoagulable state 
or other pro-thrombotic condition is present (Table). 
Hyperhomocysteinemia is one of the known causes of 
secondary venous thromboembolism (VTE) and is specifically 
linked to the occurrence of mesenteric thromboses.11-12  
Multiple studies have shown that an increased proportion 
of patients with MVT have a hypercoagulable state.3,7,9,12 A 
specific hypercoagulable state is identified in approximately 
60-75% of patients with MVT (Table).3,7,9 Prothrombotic states 
linked to MVT include antithrombin III deficiency, protein C 
or S deficiency, Factor V Leiden, prothrombin gene mutation, 
antiphospholipid antibodies, hyperhomocysteinemia, oral 
contraceptive use and malignancy.3,7 In addition, inflammatory 
states, post-operative states and trauma have been linked to 
the development of VTE.3
The link between hyperhomocysteinemia and VTE has 
been well established.11-14 The mechanism for this increased 
VTE rate, on the other hand, is not well understood.  There are 
several possible mechanisms for the increase in VTE in 
patients with hyperhomocysteinemia. A discussion of these is 
beyond the scope of this case report.11
The majority of recent studies of MVT report increased 
survival with early initiation of anticoagulation therapy.5,8,9 
Patients who are subsequently found to have a prothrombotic 
state are generally treated with lifelong anticoagulation. 
Patients with hyperhomocysteinemia are also prescribed 
supplementation of folate and B vitamins.4,11,15 
The decision to perform advanced imaging to assist in 
diagnosis of undifferentiated abdominal pain relies on history, 
physical exam and laboratory findings weighed against 
the risks associated with ionizing radiation of diagnostic 
studies and contrast media. However, clinicians should 
Figure. Computed tomography with contrast of the abdomen/pel-
vis showed a non-occlusive thrombosis of the superior mesenteric 
vein.
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consider the earlier use of contrast CT scans in patients with 
undifferentiated abdominal pain and a known or suspected 
prothrombotic state. An extensive hypercoagulable work-up in 
patients diagnosed with MVT is recommended, along with a 
referral to a hematologist.16,17
CONCLUSION
Abdominal pain represents one of the most common 
chief complaints of patients presenting to the ED. This case 
highlights a non-occlusive SMV thrombosis that mimicked the 
clinical presentation of acute appendicitis. This atypical cause 
of abdominal pain historically has been difficult to diagnose 
and resulted in significant mortality and morbidity. Contrast 
enhanced CT helps to differentiate the etiology of the more 
than three million cases of undifferentiated abdominal pain 
seen annually. In the case of mesenteric vein thrombosis, it 
has led to earlier recognition, which in turn has allowed for 
increased use of non-surgical treatment. This paradigm shift 
has led to improved outcomes and decreased mortality in 
patients that present with mesenteric vein thrombosis.
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Table. Causes of mesenteric venous thrombosis (MVT).
PRIMARY MVT
Idiopathic
SECONDARY MVT
Inherited hypercoagulability:
Factor V Leiden Deficiency
Antithrombin deficiency
Protein C and protein S deficiency
G20210A mutation in prothrombin gene
Hyperhomocysteinemia (MTHFR CBS polymorphisms)
Dysfibrinogenemia
Antiphospholipid syndrome
Abdominal etiology:
Surgical abdominal interventions: 
-  Splenectomy
-  Portocaval surgery 
-  Sclerotherapy for esophageal varices
Blunt Abdominal Trauma
Intra-abdominal infection/inflammation:
-  Appendicitis 
-  Pylephlebitis 
-  Diverticulitis 
-  Pancreatitis 
-  Peritonitis
Inflammatory bowel diseases
Other:
Cancer
Hematological disorders 
-  Polycythemia vera 
-  Essential thrombocythemia 
-  Paroxysmal nocturnal hemoglobinuria
Decompression sickness
Liver cirrhosis
Pregnancy
Oral contraceptive use
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